Company News
Alembic Pharma Expands DifGen Collaboration for US Complex Generics
Alembic Pharmaceuticals expands strategic collaboration with DifGen Pharmaceuticals to commercialize a portfolio of 20+ complex generics in the US market.
The portfolio targets a $5 billion reference
